According to previous studies, a number of inflammatory and autoimmune conditions, such as Crohn’s disease, cirrhosis, obesity, atherosclerosis, cancer, multiple sclerosis (MS), RA, and osteoarthritis (OA), have elevated SPP1 concentrations (40, 60–62). This evidence concerns the gene SPP1 and myeloid sarcoma.